Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Aortix System. Aortix is a circulatory support device for chronic heart failure...
Ventricular Assist Devices (VAD)
This channel includes news and new technology innovations for ventricular assist devices (VAD). VADs are a type of mechanical hemodynamic support device that helps increase blood flow in people who have ventricles that are not work properly due to heart failure, cardiogenic shock, cardiomyopathy or myocardial infarction. Most often these devices support the left ventricle, so they are often referred to as left ventricular assist devices (LVAD). VADS come in two types, surgically implanted, usually as a bridge to heart transplant, and percutanenous catheter-based pumps used for temporary hemodynamic support. Examples of temporary percutaneous pumps include the Impella and TandemHeart devices.
-
-
The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and Impella LD premarket approval (PMA) labeling for the treatment of cardiogenic shock. The...
-
Abiomed announced that, on April 26, the U.S. Food and Drug Administration (FDA) approved initiation of the ST-Elevation Myocardial Infarction Door-to-Unloading (STEMI DTU) Pivotal Randomized...
-
Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for acute myocardial infarction (AMI) cardiogenic shock. At the...
News | Ventricular Assist Devices (VAD) | September 12, 2019
September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its...
Paul Tang, M.D., Ph.D., a cardiac surgeon at Michigan Medicine’s Frankel Cardiovascular Center in the OR. Image courtesy of Michigan Medicine.
News | Ventricular Assist Devices (VAD) | August 20, 2019
August 20, 2019 — Left...
Technology | Heart Failure | July 30, 2019
July 30, 2019 – Procyrion Inc. secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA...
News | Ventricular Assist Devices (VAD) | June 12, 2019
June 12, 2019 — In a letter sent to healthcare providers, the U.S. Food and Drug Administration (FDA) validates that...
News | Ventricular Assist Devices (VAD) | May 22, 2019
May 22, 2019 — Abiomed announced that the Impella CP with SmartAssist will be commercially available beginning at...
Technology | Ventricular Assist Devices (VAD) | May 14, 2019
May 14, 2019 — The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and...
News | Ventricular Assist Devices (VAD) | May 02, 2019
May 2, 2019 — Abiomed announced that, on April 26, the U.S. Food and Drug Administration (FDA) approved initiation...
The Abiomed Impella percutaneous heart pump during a procedure at Henry Ford Hospital.
Podcast | Hemodynamic Support Devices | May 02, 2019
This podcast is a discussion with ...
The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.
Feature | Heart Failure | April 29, 2019 | Will Clifton, M.D.
The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms....
News | Ventricular Assist Devices (VAD) | April 05, 2019
April 5, 2019 — Three years ago this week, Abiomed's Impella...
Illustration showing the venous implantation route and where the inlet and outflow ports are when the Impella RP is placed in the right side of the heart.
Feature | Hemodynamic Support Devices | March 26, 2019 | Perwaiz Meraj, M.D. FACC and Uma Chandrasekaran, Ph.D.
Right heart failure (RHF) is a syndrome characterized by the inability of the right ventricle (RV) to support...
News | Ventricular Assist Devices (VAD) | March 22, 2019
March 22, 2019 — Severely ill patients with advanced...
Sponsored Content | Videos | Heart Failure | February 13, 2019
